Genetic test predicts 10-year risk of DCIS recurrence

SAN ANTONIO – A genetic assay specific for ductal cancer in situ accurately predicted 10-year recurrence risk in women who underwent breast-conserving surgery as treatment for the disease. Women...

Field of Interest: Oncology
Type: News Item

Genetic test predicts 10-year risk of DCIS recurrence

SAN ANTONIO – A genetic assay specific for ductal cancer in situ accurately predicted 10-year recurrence risk in women who underwent breast-conserving surgery as treatment for the disease. Women...

Field of Interest: Pulmonology
Type: News Item

Acupuncture beats gabapentin for hot flashes in RCT

SAN ANTONIO – Electroacupuncture proved significantly more effective than gabapentin for treatment of hot flashes in breast cancer survivors in a randomized, placebo-controlled clinical trial....

Field of Interest: Oncology
Type: News Item

Acupuncture beats gabapentin for hot flashes in RCT

SAN ANTONIO – Electroacupuncture proved significantly more effective than gabapentin for treatment of hot flashes in breast cancer survivors in a randomized, placebo-controlled clinical trial....

Field of Interest: Pulmonology
Type: News Item

AI-induced symptoms don’t predict survival

Vasomotor and musculoskeletal symptoms associated with aromatase inhibitor adjuvant therapy do not signal a more intense treatment response and thus do not predict better survival in women with...

Field of Interest: Pulmonology
Type: News Item

Prostate cancer surveillance appears safe through 15 years

Active surveillance appears to be safe through 15 years of follow-up for men who have low-risk prostate cancer, according to a report published online Dec. 15 in the Journal of Clinical Oncology. In...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness